Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Pittsburgh
Brain Inflammation Collaborative
M.D. Anderson Cancer Center
Radboud University Medical Center
Odense University Hospital
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Universitaire Ziekenhuizen KU Leuven
Sanguine Biosciences
Assistance Publique - Hôpitaux de Paris